inflammatory and degenerative diseases of the musculoskeletal system including: rheumatoid arthritis, ankylosing spondylitis and other spopdiloarthropathies, osteoarthritis, gouty arthritis, bursitis, tenosynovitis, pain syndromes from the spine (lumbago, ischialgia, ossalgia, neuralgia, myralgia, radialgia);
renal and biliary colic;
post-traumatic and postoperative pain syndrome, accompanied by inflammation;
The dose of the drug is selected individually, while in order to reduce the risk of side effects, it is recommended to use the minimum effective dose, if possible, with the shortest possible treatment period, in accordance with the purpose of treatment and the patient's condition.
The drug Diclofenac Velfarm in ampoules is especially suitable for the initial treatment of inflammatory and degenerative rheumatic diseases, as well as pain due to inflammation of non-rheumatic origin.
The drug Diclofenac Velfarm is administered by deep injection into the gluteal muscle.
Do not use Diclofenac Velfarm injection for more than 2 consecutive days. If necessary, treatment can be continued with diclofenac in tablets or rectal suppositories.
When carrying out an intramuscular injection in order to avoid damage to the nerve or other tissues at the injection site (which can lead to muscle weakness, paresis or decreased sensitivity), it is recommended to adhere to the following rules.
The drug should be administered deeply intramuscularly into the upper outer quadrant of the gluteal region in compliance with aseptic rules.
The dose is usually 75 mg (contents of 1 ampoule) 1 time per day.
In severe cases (for example, with colic), as an exception, 2 injections of 75 mg can be performed with an interval of several hours (the second injection should be carried out in the contralateral buttock).
Alternatively, one injection of the drug per day (75 mg) can be combined with other dosage forms of diclofenac (tablets, rectal suppositories), while the total daily dose should not exceed 150 mg.
For migraine attacks, treatment is started as soon as possible after the start of the attack with the IM administration of the drug Diclofenac Velfarm in a dose of 75 mg (1 ampoule). If necessary, it is possible to use diclofenac in other dosage forms, while the total daily dose should not exceed 150 mg per day.
The solution of the drug should be clear. Do not use a solution with a crystalline or other precipitate.
The ampoule of the drug should be used only once. The solution should be administered immediately after opening the ampoule. After a single use, unused residues of the solution of the drug Diclofenac Velfarm must be disposed of in accordance with local requirements.
Do not mix the solution of the drug Diclofenac Velfarm contained in ampoules with solutions of other drugs for injection.
Children and adolescents under 18
diclofenac wellpharm, a solution for intramuscular administration, should not be used in children and adolescents under 18 years of age due to the difficulty of dosing the drug; if treatment is necessary in this category of patients, diclofenac can be used in tablets or suppositories
Elderly patients (≥ 65 years old)
correction of the initial dose in patients aged 65 years and older, as a rule, is not required. However, for general medical reasons, caution should be exercised in debilitated elderly patients or patients with low body weight
Patients with diseases of the cardiovascular system or a high risk of diseases of the cardiovascular systemмы
it should be used with extreme caution in patients with diseases of the cardiovascular system or a high risk of developing diseases of the cardiovascular system. If necessary, long-term therapy (more than 4 weeks) in such patients, the drug should be used in a daily dose not exceeding 100 mg
Patients with impaired renal function
there is no data on the need for dose adjustment when using the drug in patients with impaired renal function due to the lack of studies of the safety of the drug in patients of this category. Caution should be exercised when using the drug in patients with impaired renal function. The use of the drug in patients with renal failure (GFR less than 15 ml / min 1.73 square meters of body surface area) is contraindicated
Patients with impaired liver function
there is no data on the need for dose adjustment when using the drug in patients with impaired liver function of mild to moderate severity due to the lack of studies of the safety of the drug in this category of patients. The use of the drug in patients with severe liver dysfunction is contraindicated
There are contraindications, consult with a specialist before use